Research Topics
| Frederick C EilberSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Diagnosis and management of synovial sarcomaFritz C Eilber
Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California 90095 1782, USA
J Surg Oncol 97:314-20. 2008..Although ifosfamide based chemotherapy has been associated with an improved survival in patients with synovial sarcoma, the search for less toxic and more targeted systemic therapies is ongoing...
High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortalityFritz C Eilber
Division of Surgical Oncology, 54 140 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095 1782, USA
Ann Surg 237:218-26. 2003..To identify patient characteristics associated with the development of local recurrence and the effect of local recurrence on subsequent morbidity and mortality in patients with intermediate- to high-grade extremity soft tissue sarcomas...
Targeted therapies for soft-tissue sarcomasWilliam D Tap
UCLA Sarcoma Program, Division of Hematology Oncology, Los Angeles, CA 90095 7059, USA
Expert Rev Anticancer Ther 7:725-33. 2007..This review will outline current areas of therapeutic interest in soft-tissue sarcomas with regard to agents that have reached clinical testing...- Advances in chemotherapy for patients with extremity soft tissue sarcomaFritz C Eilber
University of California, Los Angeles, UCLA Medical Center, 90095 1782, USA
Orthop Clin North Am 37:15-22. 2006..Until a less toxic targeted systemic therapy is developed, treatment with ifosfamide should be strongly considered in patients who have high-risk primary extremity soft tissue sarcomas... - Sarcoma nomogram: validation and a model to evaluate impact of therapyFrederick C Eilber
Division of Surgical Oncology, University of California, Los Angeles, CA 90095-1782, USA
J Am Coll Surg 205:S90-5. 2007 - Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcomaFritz C Eilber
Division of Surgical Oncology, University of California Los Angeles, Los Angeles, CA, USA
Ann Surg 246:105-13. 2007..To determine if ifosfamide-based chemotherapy (IF) offers a survival benefit to adult patients with primary extremity synovial sarcoma... - FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomasMatthias R Benz
Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90095 1782, USA
Clin Cancer Res 15:2856-63. 2009.... - The Friedman-Eilber resection arthroplasty of the pelvisAdam J Schwartz
Department of Orthopaedic Surgery, University of California, Los Angeles Medical Center, Santa Monica, 1250 16th Street, 7th Floor, Los Angeles, CA, 90404, USA
Clin Orthop Relat Res 467:2825-30. 2009..LEVEL OF EVIDENCE: Level IV, case series. See Guidelines for Authors for a complete description of levels of evidence... - Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogramTimothy R Donahue
Department of Surgery, Division of Surgical Oncology, University of California at Los Angeles, Los Angeles, California 90095 1782, USA
Cancer 116:3883-91. 2010..Patients with primary high-grade retroperitoneal soft tissue sarcomas have a 5-year disease-specific survival (DSS) of <40%. The impact of neoadjuvant therapy on histopathologic response and DSS are unknown... - The multidisciplinary management of osteosarcomaNoah Federman
Division of Pediatric Hematology Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
Curr Treat Options Oncol 10:82-93. 2009..The treatment of metastatic, recurrent and/or refractory disease is more controversial. Despite advances in systemic treatment, surgical technique, and supportive care, the overall outcome is still poor... - Utilization of positron emission tomography in the management of patients with sarcomaMatthias R Benz
Departments of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California 90095, USA
Curr Opin Oncol 21:345-51. 2009..In this review, the recent literature covering all aspects of PET imaging in the management of patients with soft tissue and bone sarcomas will be discussed... - Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomasMatthias R Benz
Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California, USA
J Nucl Med 49:1579-84. 2008..The aim of this study was to determine whether combined assessment of tumor volume and metabolic activity improves the accuracy of (18)F-FDG PET for predicting histopathologic tumor response in patients with soft-tissue sarcomas... - Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumorsMatthias R Benz
Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, University of California at Los Angeles, Los Angeles, California, USA
J Nucl Med 49:1038-46. 2008..Knowledge of the interobserver variability of quantitative parameters is important in sarcomas as these tumors are frequently large and demonstrate heterogeneous (18)F-FDG uptake...